Skin Health and Metadichol®: What This 2018 Paper Reported
In this 6th edition of Research Central, we’ll be exploring a 2018 research publication by Dr. PR Raghavan, the creator of NANO SOMA®, which describes how Metadichol® – the patented name of NANO SOMA – may affect skin health over time.*
Read on for a breakdown of the findings.
Metadichol® and Healthy Skin: One Approach
A 2018 paper published in the Journal of Clinical & Experimental Dermatology Research explored the potential role of Metadichol® (the patented name for NANO SOMA®), a nano-formulation of long-chain lipid alcohols derived from food, in supporting healthy skin function and appearance.*
The paper reviewed the biological pathways involved in skin health and presented a series of case reports involving various skin-related concerns. To read the full published paper, click here.
Why Skin Health Matters
Dr. Raghavan begins by noting that the skin is the body’s largest organ and plays critical roles in protection, immune defense, temperature regulation, and vitamin D production. Skin-related issues affect millions of people worldwide and can significantly impact quality of life.
According to the paper, many skin concerns involve complex interactions between immune signaling pathways, inflammatory responses, environmental factors, and genetics. This complexity makes it challenging to address skin health through a single biological target.
Metadichol®’s Role
The paper describes Metadichol as a patented, nano-lipid formulation that encourages the healthy function and maintenance of several important biological receptors,* including:
- Vitamin D Receptor (VDR)
- Aryl Hydrocarbon Receptor (AHR)
- Retinoic Acid Receptor-Related Orphan Receptor Gamma (RORγ)
- Tumor Necrosis Factor Alpha (TNF-α) pathways
Dr. Raghavan proposes that these interactions may influence immune signaling networks involved in skin function, including pathways associated with T-helper cells and cytokines such as IL-17, IL-22, and IL-23. These pathways have been widely studied in relation to skin homeostasis and immune regulation, and demonstrate the potential for addressing stubborn skin issues at a more fundamental level.
What the Paper Reported
The publication presented a collection of case reports involving individuals with a variety of skin-related concerns, including issues affecting skin appearance, skin comfort, and skin integrity. Dr. Raghavan reported observations suggesting that the presence of Metadichol was associated with improvements in these cases,* even when the issue was long-enduring.
In addition to the case reports, the paper discusses research linking vitamin D signaling, immune regulation, antimicrobial responses, tissue repair processes, and skin barrier function. Dr. Raghavan suggests that supporting these interconnected pathways can contribute to healthier skin function.*
A Systems-Based View of Skin Health
One of the central themes of the paper is that skin wellness is influenced by many biological systems working together rather than by a single pathway. Dr. Raghavan argues that particles capable of interacting with multiple regulatory networks, such as Metadichol, may offer a broader approach to supporting skin health than interventions focused on only one target. This approach aligns with MagicDichol®’s own vision of inviting in good health in a holistic, natural way – rather than attempting to manage symptoms or put band-aids over stubborn issues and ignoring their root cause.
The paper refers to this concept as a “polypharmacological” approach, where one substance (such as Metadichol) may influence several biological pathways simultaneously.
Where NANO SOMA® Comes In
This publication proposes that Metadichol (the patented name for NANO SOMA®) may support healthy skin through interactions with multiple immune and regulatory pathways, including VDR, AHR, RORγ, and TNF-α signaling networks, allowing the body to address the underlying issues behind skin health in a more comprehensive, supported way.*
Dr. Raghavan’s case-report evidence suggests positive outcomes across a range of skin-related concerns and advocates for further research into multi-target approaches to skin wellness.
While larger controlled studies are needed before firm clinical conclusions can be drawn, these results are a powerful indicator of skin health success with NANO SOMA – an outcome corroborated by user testimonials across the globe.
Compliance Note
The paper discusses research findings and proposed biological mechanisms. The findings should not be interpreted as evidence that NANO SOMA or any MagicDichol® product treats, cures, or prevents disease. Any observed benefits are described as support for the body’s natural regulatory processes* rather than direct therapeutic effects.
Are You Ready To See What It Can Do For You?
Tap the button below and discover how you can!
*These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose or prescribe for any medical condition, nor to prevent, treat, mitigate, or cure such condition(s). If you have any illness or medical condition, consult your healthcare provider.
